Tia L Bush insider trades

Open-market stock purchases and sales by Tia L Bush, Chief Technology & Quality Ofc at Centessa Pharmaceuticals plc, from SEC Form 4 filings since May 7, 2021.

Track record: 100% of 3 scored buys are up 5% or more since purchase, averaging +180%.

Recent trades

DateStockTradeValue
Jun 24, 2026CNTA Centessa Pharmaceuticals plcSold (not open market)—
Jun 24, 2026CNTA Centessa Pharmaceuticals plcSold (not open market)$3.4M
Jun 24, 2026CNTA Centessa Pharmaceuticals plcSold (not open market)$105K
Jun 24, 2026CNTA Centessa Pharmaceuticals plcSold (not open market)$1.2M
Jun 24, 2026CNTA Centessa Pharmaceuticals plcSold (not open market)$2.1M
Jun 24, 2026CNTA Centessa Pharmaceuticals plcSold (not open market)$3.5M
Feb 2, 2026CNTA Centessa Pharmaceuticals plcBought (not open market)—
Feb 2, 2026CNTA Centessa Pharmaceuticals plcBought (not open market)—
Feb 1, 2026CNTA Centessa Pharmaceuticals plcSold (not open market)$210K
Nov 17, 2025CNTA Centessa Pharmaceuticals plcBought (not open market)—
Nov 17, 2025CNTA Centessa Pharmaceuticals plcSold$1.1M
Nov 12, 2025CNTA Centessa Pharmaceuticals plcSold$1M
Nov 12, 2025CNTA Centessa Pharmaceuticals plcBought (not open market)—

Companies traded

  • CNTA Centessa Pharmaceuticals plc: 3 buys, 12 sales, last Jun 24, 2026

Get free alerts when Tia L Bush files a new trade →